Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ATXI Avenue Therapeutics

Watchlist
11.510
+1.430+14.19%
Close 10/03 16:00 ET
12.940
+1.43+12.42%
Pre Mkt Price 10/04 07:24 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
15.510
Open
13.970
Turnover
223.56M
Low
11.350
Pre Close
10.080
Volume
16.03M
Market Cap
17.42M
P/E(TTM)
Loss
52wk High
27.750
Shares
1.51M
P/E(Static)
Loss
52wk Low
3.000
Float Cap
9.17M
Bid/Ask %
33.33%
Historical High
185.097
Shs Float
797.06K
Volume Ratio
0.80
Historical Low
3.000
Dividend TTM
--
Div Yield TTM
--
P/B
29.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2010.97%
Amplitude
41.27%
Avg Price
13.947
Lot Size
1
Float Cap
9.17M
Bid/Ask %
33.33%
Historical High
185.097
Shs Float
797.06K
Volume Ratio
0.80
Historical Low
3.000
Dividend TTM
--
P/B
29.51
Dividend LFY
--
Turnover Ratio
2010.97%
Amplitude
41.27%
Avg Price
13.947
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top